Skip to main content
. 2017 Jan;58(1):79–86. doi: 10.1167/iovs.16-20485

Figure 1.

Figure 1

Ang-2 blockade significantly improved corneal graft survival. (A) Representative slit-lamp micrographs demonstrating rejected and survived corneal grafts in the control and treatment groups, respectively, at 8 weeks after transplantation. Scale bar: 1 mm. (B) Summarized data showing anti-Ang-2–treated corneas had lower opacity scores at all time-points studied. ***P < 0.001. (C) Kaplan-Meier survival curves showing anti-Ang-2–treated corneas enjoyed higher rate of survival. *P < 0.05.